Barclays PLC Kiniksa Pharmaceuticals, Ltd. Put Options Transaction History
Barclays PLC
- $327 Billion
- Q2 2024
Put Options
2 transactions
Others Institutions Holding KNSA
# of Institutions
11Shares Held
1.89MCall Options Held
0Put Options Held
0-
Pictet Asset Management Sa Geneva 73, V81.52MShares$38.3 Million0.03% of portfolio
-
Spearhead Capital Advisors, LLC Wellington, FL203KShares$5.12 Million2.82% of portfolio
-
Putnam Investments LLC Boston, MA39.5KShares$997,4160.0% of portfolio
-
Birchview Capital, LP Burlington, VT30KShares$757,8000.56% of portfolio
-
Credit Suisse Ag Zurich, V828.9KShares$730,6200.0% of portfolio
About Kiniksa Pharmaceuticals, Ltd.
- Ticker KNSA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,470,400
- Market Cap $871M
- Description
- Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...